Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pacritinib For The Reduction Of Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia; A Multicenter, Open-Label, Single Arm, Phase II Exploratory Study

NCT07394153 is registered in ClinicalTrials.gov with Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas as lead sponsor.

NCT NCT07394153
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07394153 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pacritinib For The Reduction Of Bone Marrow Fibrosis In Patients With Myelofibrosis Who Have Thrombocytopenia; A Multicenter, Open-Label, Single Arm, Phase II Exploratory Study
Lead sponsor
Grupo Español de Enfermedades Mieloproliferativas Crónicas PH Negativas
Phase
Phase 2
Overall status
Recruiting
Start date
April 15, 2026
Completion date
June 30, 2028
Enrollment
30 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

myelofibrosis，mf